Blog
About

0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      CLINICAL EFFICACY OF A BETABLOCKERS THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE ON THE BACKGROUND OF POSTINFARCTION CARDIOSCLEROSIS

      , , , , , Belgorod State University, Belgorod State University, Belgorod State University, Kursk State Medical University, Burdenko Voronezh state medical University

      RESEARCH RESULT Pharmacology and Clinical Pharmacology

      Belgorod National Research University

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Despite the fact that betablockers (BBs) are one of the main groups of therapy of patients with acute myocardial infarction (AMI), the comparative effectiveness of various BBs in patients with postinfarction cardiosclerosis (PICS) is uncertain. There was performed comparative analysis of clinical efficacy of BBs in patients with chronic heart failure (CHF) on the background of coronary heart disease (CHD), PICS. There was evaluated the impact of metoprolol succinate, carvedilol, bisoprolol and betaxolol on blood pressure (BP), left ventricular ejection fraction (LVEF), change the functional class of chronic heart failure, and mortality in patients over 4 years. It is established that the BBs therapyblood pressure decreased equally, without significant differences between the groups (р˃0,05). There was a positive effect on the increase of the LVEF all the BBs (p

          Related collections

          Author and article information

          Journal
          RESEARCH RESULT Pharmacology and Clinical Pharmacology
          RR.P and CP
          Belgorod National Research University
          2500235X
          2017
          2017
          : 3
          : 1
          Article
          10.18413/2500-235X-2017-3-1-90-96
          © 2017
          Product

          Comments

          Comment on this article